Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma

Parameswaran Nair , Sally Wenzel , Klaus F. Rabe , Arnaud Bourdin (1, 2) , Njira L. Lugogo , Piotr Kuna , Peter Barker , Stephanie Sproule , Sandhia Ponnarambil , Mitchell Goldman

1 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]
2 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]

Mots clés: Interleukin-5 Receptor alpha Subunit; Subcutaneous; Injections; Double-Blind Method; Asthma; Middle Aged; Drug; Glucocorticoids; Anti-Asthmatic Agents; Humans; Female; Male; Antibodies; Monoclonal; Humanized; Administration; Oral; Adult; Dose-Response Relationship

Domaines: Sciences du Vivant [q-bio]

Parameswaran Nair, Sally Wenzel, Klaus F. Rabe, Arnaud Bourdin, Njira L. Lugogo, et al.. Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma. New England Journal of Medicine, 2017, 376 (25), pp.2448--2458. ⟨10.1056/NEJMoa1703501⟩. ⟨hal-01761510⟩